Table of Contents
India’s robust healthcare landscape makes understanding medical device import regulations India vital for global suppliers and innovators seeking successful market entry. Complying with these regulations ensures legal clearance, patient safety, and smooth distribution of medical devices across India.
India regulates imported medical devices under the Medical Devices Rules, 2017 and related CDSCO guidelines. Foreign manufacturers cannot directly apply for import permissions and must engage an Authorized Indian Agent.
These regulations categorize devices by risk and ensure quality, safety, and effectiveness before importation and distribution. Compliant entry helps avoid customs delays, rejections, and enforcement actions.
The CDSCO import license process is central to legally bring medical devices into India. The Central Drugs Standard Control Organization (CDSCO) evaluates risk class, documentation, and compliance before granting approval.
Foreign companies must appoint an Indian agent licensed to submit the application and interact with CDSCO.
What Are Form MD-14 & MD-15 India?
These forms are mandatory for importing notified devices — those officially recognized under the Medical Devices Rules. Validity & Retention: Under MDR 2017 and CDSCO guidance, import licenses operate with perpetual validity subject to payment of retention fees and submission of updated documents every five years; some guidance summarises this as “5year validity with renewal,” but retention maintains continuity.
Strong documentation is crucial to medical device compliance India and timely import approval.
Required Documents Checklist:
Inaccurate documents often lead to application rejection or delays. Early audit and compliance checks help avoid setbacks.
Tip: Use the official CDSCO checklists for MD14 to preaudit files and avoid avoidable queries. [cdsco.gov.in]
Table 1: CDSCO forms used for medical device import regulations India.
| Form Number | Purpose | Issued/Submitted By |
| MD-14 | Import license application | Authorized Agent |
| MD-15 | Import license approval | CDSCO |
| MD-16 | Test import application | Authorized Agent |
| MD-17 | Test license issuance | CDSCO |

After receiving Form MD-15 India, importers must continue medical device post market compliance India. This includes recordkeeping, adverse event reporting, product labeling updates, and fee retention.
Failure in post-market compliance might result in CDSCO enforcement, license suspension, or product recalls.
For a small quantity of imports for research or demonstration, the importer may obtain a test license using Form MD-16 (application) and Form MD-17 (approval).
A separate clinical investigation of permission may also be required for certain new or high-risk devices before importing or marketing.
Government fees vary by risk class, manufacturing site, and device count (same fee levels apply for retention every 5 years):
Noncompliance may trigger license suspension/cancellation, recalls, seizures, and other enforcement under MDR 2017 and the Drugs & Cosmetics Act. Maintain a proactive PMS and respond to CDSCO notices promptly
Successfully navigating medical device import regulations India requires a strategic approach — from understanding CDSCO mechanisms through the CDSCO import license process to completing Forms MD-14 & MD-15 India and maintaining medical device compliance India post-approval.
Saurangi is a food regulatory expert with 8 years of experience. She shares her knowledge and insights on regulatory updates, food trends, best practices, and news. Follow her for expert insights and practical advice on all things for food regulatory
CliniExperts Services Pvt. Ltd.
The Categorisation Problem Of all the challenges in India’s Cosmetic Import registration process, product categorisation is one of the most underestimated. Under the Cosmetics Rules, 2020, CDSCO..
For foreign Medical Device companies entering India, the authorized agent is not just a compliance checkpoint — it is a strategic regulatory role. The right appointment can support licensing procedu..
Why India Demands a Dedicated Biosimilar Strategy India is one of the fastest-growing Biosimilar markets in the world, driven by a large patient population, expanding government healthcare coverage un..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)